• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Fifth Third Bancorp filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    4/15/25 2:36:08 PM ET
    $FITB
    Major Banks
    Finance
    Get the next $FITB alert in real time by email
    fitb-20250415
    false0000035527Fifth Third BancorpDepositary Shares Representing a 1/1000th Ownership Interest in a Share of 6.625% Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock00000355272025-04-152025-04-150000035527us-gaap:CommonStockMember2025-04-152025-04-150000035527fitb:DepositarySharesRepresentingA11000thOwnershipInterestInAShareOf6.625FixedToFloatingRateNotCumulativePerpetualPreferredStockSeriesI2Member2025-04-152025-04-150000035527fitb:DepositarySharesRepresentingA140thOwnershipInterestInAShareOf6.00NotCumulativePerpetualClassBPreferredStockSeriesAMember2025-04-152025-04-150000035527fitb:DepositarySharesRepresentingA11000thOwnershipInterestInAShareOf4.95NotCumulativePerpetualPreferredStockSeriesKMember2025-04-152025-04-15

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, DC 20549
    FORM 8-K
    CURRENT REPORT
    PURSUANT TO SECTION 13 OR 15(D)
    OF THE SECURITIES EXCHANGE ACT OF 1934
    Date of report (Date of earliest event reported): April 15, 2025
    ER - FITB Shield v2.gif
    (Exact name of registrant as specified in its charter)
    Ohio 001-33653 31-0854434
    (State or other jurisdiction
    of incorporation)
     (Commission
    File Number)
     (IRS Employer
    Identification No.)
    Fifth Third Center
    38 Fountain Square Plaza,Cincinnati,Ohio45263
    (Address of Principal Executive Offices)(Zip Code)
    (800) 972-3030
    (Registrant's telephone number, including area code)

    Not Applicable
    (Former name or former address, if changed since last report)

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below)

        ☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

        ☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

        ☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

        ☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each class Trading
    Symbol(s)
     Name of each exchange
    on which registered
    Common Stock, Without Par Value FITB The NASDAQ Stock Market LLC
    Depositary Shares Representing a 1/1000th Ownership Interest in a Share of 6.625% Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock, Series I FITBI The NASDAQ Stock Market LLC
    Depositary Shares Representing a 1/40th Ownership Interest in a Share of 6.00% Non-Cumulative Perpetual Class B Preferred Stock, Series A FITBP The NASDAQ Stock Market LLC
    Depositary Shares Representing a 1/1000th Ownership Interest in a Share of 4.95% Non-Cumulative Perpetual Preferred Stock, Series K FITBO The NASDAQ Stock Market LLC

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company    ☐            

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐




    Item 7.01 Regulation FD Disclosure

    On April 15, 2025, the following presentation will be made during the 2025 Annual Meeting of Shareholders of Fifth Third Bancorp. A copy of this presentation is attached as Exhibit 99.1.

    The information in this Form 8-K and Exhibits attached hereto shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall they be deemed incorporated by reference in any filing under the Securities Exchange Act of 1934 or the Securities Act of 1933, except as shall be expressly set forth by specific reference.

    Item 9.01 Financial Statements and Exhibits

    Exhibit 99.1 – Fifth Third Bancorp Presentation

    Exhibit 104 – Cover Page Interactive Data File (embedded within the Inline XBRL document)




    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     FIFTH THIRD BANCORP
     (Registrant)
       
    Date: April 15, 2025
    /s/ Bryan D. Preston
       
     Bryan D. Preston
     Executive Vice President and
    Chief Financial Officer


    Get the next $FITB alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $FITB

    DatePrice TargetRatingAnalyst
    5/21/2025$47.00Buy
    Jefferies
    5/15/2025$52.00Buy
    TD Cowen
    4/7/2025$47.00Neutral → Outperform
    Robert W. Baird
    5/31/2024$43.00Peer Perform → Outperform
    Wolfe Research
    5/1/2024$37.50 → $39.50Neutral → Overweight
    JP Morgan
    4/1/2024$32.00Outperform → Neutral
    Robert W. Baird
    3/19/2024$41.00Overweight → Equal-Weight
    Stephens
    1/9/2024$33.00 → $37.00Outperform → Mkt Perform
    Keefe Bruyette
    More analyst ratings